Imperial College London

DrSarahOnida

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3311 7317s.onida Website

 
 
//

Location

 

4N 12North WingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ravikumar:2021:10.1177/0268355520968640,
author = {Ravikumar, R and Lane, TRA and Babber, A and Onida, S and Davies, AH},
doi = {10.1177/0268355520968640},
journal = {Phlebology},
pages = {290--302},
title = {A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status},
url = {http://dx.doi.org/10.1177/0268355520968640},
volume = {36},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BackgroundThis randomised controlled trial investigates the dosing effect of neuromuscular electrical stimulation (NMES) in patients with chronic venous disease (CVD).MethodsSeventy-six patients with CEAP C3-C5 were randomised to Group A (no NMES), B (30 minutes of NMES daily) or C (60 minutes of NMES daily). Primary outcome was percentage change in Femoral Vein Time Averaged Mean Velocity (TAMV) at 6 weeks. Clinical severity scores, disease-specific and generic quality of life (QoL) were assessed.ResultsSeventy-six patients were recruited - mean age 60.8 (SD14.4) and 47:29 male. Six patients lost to follow-up. Percentage change in TAMV (p<0.001) was significantly increased in Groups B and C. Aberdeen Varicose Veins Questionnaire Score (-6.9, p=0.029) and Venous Clinical Severity Score (-4, p-0.003) improved in Group C, and worsened in Group A (+1, p=0.025).ConclusionsDaily NMES usage increases flow parameters, with twice daily usage improving QoL and clinical severity at 6 weeks in CVD patients.
AU - Ravikumar,R
AU - Lane,TRA
AU - Babber,A
AU - Onida,S
AU - Davies,AH
DO - 10.1177/0268355520968640
EP - 302
PY - 2021///
SN - 0268-3555
SP - 290
TI - A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status
T2 - Phlebology
UR - http://dx.doi.org/10.1177/0268355520968640
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000624869900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://journals.sagepub.com/doi/10.1177/0268355520968640
UR - http://hdl.handle.net/10044/1/89463
VL - 36
ER -